Before revision:  In these results, interesting signaling pathways and GOs such as  JAK-STAT, IRF7-NFkB signaling, and MYD88/CXCR6 immune signaling were identified. Many drugs were identified with downstream inhibition of these signaling pathways and GOs, and many of which are currently undergoing clinical trial evaluation.
After revision:  In these results, interesting signaling pathways and GOs such as JAK-STAT, IRF7-NFkB signaling, and MYD88/CXCR6 immune signaling were particularly identified. Based on the identified signaling pathways and GOs, and many of which are currently undergoing clinical trial evaluation.